DistantNews
Support us
Swiss financial firm Haute Capital under Finma investigation for suspected stock manipulation
๐Ÿ‡จ๐Ÿ‡ญ Switzerland /Crime & Justice

Swiss financial firm Haute Capital under Finma investigation for suspected stock manipulation

From Le Temps · () French

Translated from French, summarized and contextualized by DistantNews.

At a glance

News Sources not specified Under investigation
  • Swiss financial company Haute Capital is under investigation by the Swiss Financial Market Supervisory Authority (Finma).
  • The investigation reportedly involves suspicions of stock price manipulation.
  • The company's auditor could not confirm the value of one of its holdings, and its stock has fallen significantly.

Haute Capital, a financial company based in Biel, Switzerland, is currently under investigation by the Swiss Financial Market Supervisory Authority (Finma). The probe is reportedly focused on suspicions of stock price manipulation.

The company's 2025 financial results, released in early June, revealed a loss of 4.4 million francs. However, the auditor's report for these results could not definitively confirm the value of one of Haute Capital's significant holdings. This uncertainty, coupled with a sharp decline in its stock price, down 65% since January, has led to dissatisfaction among some shareholders.

Haute Capital, which is listed on the Bern Stock Exchange, has seen its share price plummet from a high of 120 francs. The stock had experienced a steady increase of 180% since its IPO in May 2022. The company claims it is reinventing itself as a specialist in Swiss private equity.

Finma's investigation adds to the challenges faced by the company, which has attracted attention since June 2024 due to its consistent stock performance prior to the recent downturn. The company's founder and CEO is expected to address these issues.

DistantNews Editorial

Originally published by Le Temps in French. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.